New prodrug activation gene therapy for cancer using cytochrome P450 4B1 and 2-aminoanthracene/4-ipomeanol

Human Gene Therapy

Volumn 9, Issue 9, 1998, Pages 1261-1273

  Rainov, Nikolai G ^a,b   Dobberstein, Karl Ulrich ^b   Sena Esteves, Miguel ^a   Herrlinger, Ulrich ^a   Kramm, Christof M ^c   Philpot, Richard M ^d   Hilton, John ^e   Antonio Chiocca, E ^a   Breakefield, Xandra O ^a,f  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINOANTHRACENE; 4 IPOMEANOL; CYTOCHROME P450; DNA FRAGMENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN TUMOR; CANCER CELL CULTURE; CELL CONTACT; CELL KILLING; CONTROLLED STUDY; DNA PROTEIN COMPLEX; DRUG ACTIVATION; DRUG TOXICITY; GENE THERAPY; GENETIC ENGINEERING; GLIOMA CELL; HUMAN; HUMAN CELL; NONHUMAN; RAT;

ANIMALIA; MUS MUSCULUS; ORYCTOLAGUS CUNICULUS; RODENTIA;

EID: 0032503657     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1998.9.9-1261     Document Type: Article

References (13)

1. BOYD, M.R. (1976). Role of metabolic activation in the pathogenesis of chemically induced pulmonary disease: mechanism of action of the lung-toxic furan, 4-ipomeanol. Environ. Health Perspect. 16, 127-138.
2. BOYD, M.R., and BURKA, L.T. (1978). In vivo studies on the relationship between target organ alkylation and the pulmonary toxicity of a chemically reactive metabolite of 4-ipomeanol. J. Pharmacol. Exp. Ther. 207, 687-697.
3. BOYD, M.R., WILSON, B.J., and HARRIS, T.M. (1972). Confirmation by chemical synthesis of the structure of 4-ipomeanol, a lung-toxic metabolite of the sweet potato, Ipomoea batatas. Nature New Biol. 236, 158-159.
4. BOYD, M.R., STIKO, A., STATHAM, C.N., and JONES, R.B. (1982). Protective role of endogenous pulmonary glutathione and other sulfhydryl compounds against lung damage by alkylating agents. Investigations with 4-ipomeanol in the rat. Biochem. Pharmacol. 31, 1579-1583.
5. BUCKPITT, A.R., and BOYD, M.R. (1980). The in vitro formation of glutathione conjugates with the microsomally activated pulmonary bronchiolar alkylating agent and cytotoxin, 4-ipomeanol. J. Pharmacol. Exp. Ther. 215, 97-103.
6. CHEN, L., and WAXMAN, D.J. (1995). Intratumoral activation and enhanced chemotherapeutic effect of oxazaphosphorines following cytochrome P-450 gene transfer: Development of a combined chemotherapy/cancer gene therapy strategy. Cancer Res. 55, 581-589.
7. CHRISTIAN, M.C., WITTES, R.E., LEYLAND-JONES, B., MCLEMORE, T.L., SMITH, A.C., GRIESHABER, C.K., CHABNER, B.A., and BOYD, M.R. (1989). 4-Ipomeanol: A novel inves tigational new drug for lung cancer. J. Natl. Cancer. Inst. 81, 1133-1143.
8. CULVER, K.W., RAM, Z., WALBRIDGE, S., ISHII, H., OLDFIELD, E.H., and BLAESE, R.M. (1992). In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256, 1550-1552.
9. CZERWINSKI, M., MCLEMORE, T.L., PHILPOT, R.M., NHAMBURO, P.T., KORZEKWA, K., GELBOIN, H.V., and GONZALEZ, F.J. (1991). Metabolic activation of 4-Ipomeanol by complementary DNA-expressed human cytochromes p-450: Evidence for species-specific metabolism. Cancer Res. 51, 4636-4638.
10. CZERWINSKI, M., MCLEMORE, T.L., GELBOIN, H.V., GONZALEZ, F.J. (1994). Quantification of CYP2B7, CYP4B1, and CYPOR messenger RNAs in normal human lung and lung tumors. Cancer Res. 54, 1085-1091.
11. DUTCHER, J.S., and BOYD, M.R. (1979). Species and strain differences in target organ alkylation and toxicities by 4-Ipomeanol: Predictive value of covalent binding in studies of target organ toxicities by reactive metabolites. Biochem. Pharmacol. 28, 3367-3372.
12. EZZEDDINE, Z.D., MARTUZA, R.L., SHORT, M.P., PLATIKA, D., MALICK, A., CHOI, B., and BREAKEFIELD, X.O. (1991). Selective killing of glioma cells in culture and in vivo following retrovirus transfer of the herpes simplex virus thymidine kinase gene. The New Biologist 3, 1-7.
13. WOLF, C.R., STATHAM, C.N., MCMENAMIN, M.G., BEND, J.R., BOYD, M.R., and PHILPOT, R.M. (1982). The relationship between the catalytic activities of rabbit pulmonary cytochrome P-450 isozymes and the lung-specific toxicity of the furan derivative, 4-ipomeanol. Mol. Pharmacol. 22, 738-744.